Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 100mg;   - capsule - 100 mg - active: temozolomide 100mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 140mg;   - capsule - 140 mg - active: temozolomide 140mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 180mg;   - capsule - 180 mg - active: temozolomide 180mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 20mg;   - capsule - 20 mg - active: temozolomide 20mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 250mg;   - capsule - 250 mg - active: temozolomide 250mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 5mg;   - capsule - 5 mg - active: temozolomide 5mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - somatropin -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - milrinone, quantity: 1 mg/ml - injection, solution - excipient ingredients: glucose monohydrate; lactic acid; sodium hydroxide; water for injections - primacor injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart patients in intensive care and coronary care units not responding to other therapy (e.g. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 13.125 g;  ;  ;  ;  ; potassium chloride 46.6mg;  ;  ; sodium bicarbonate 178.5mg;  ; sodium chloride 350.7mg;  ;  ;   - powder for oral solution - active: macrogol 3350 13.125 g         potassium chloride 46.6mg     sodium bicarbonate 178.5mg   sodium chloride 350.7mg       excipient: acesulfame potassium lime & lemon flavour trusil 463842 - for effective relief from constipation, treatment of chronic constipation. movicol is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum.

Malta - angleščina - Medicines Authority

stirling anglian pharmaceuticals ltd hillington park innovation centre, 1 ainslie road, hillington park, glasgow g52 4ru, united - macrogol, sodium chloride, sodium hydrogen, carbonate, potassium chloride - powder for oral solution - macrogol 3350 6.563 gram(s) ; sodium chloride 0.1754 gram(s) ; sodium hydrogen carbonate 0.0893 gram(s) ; potassium chloride 0.0233 gram(s) - drugs for constipation